ClinicalTrials.gov
public full text
Public Domain
NAD Supplementation and Vascular Health in PAD
This pilot open-label clinical trial was designed to investigate whether 4-week supplementation with 1g daily NR impacts endothelial function in peripheral circulation, cerebrovascular hemodynamics, cognitive function in older adults with peripheral artery disease.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Effects of NAD(+) supplementation with oral nicotinamide riboside on vascular health and cognitive function in older adults with peripheral artery disease: Results from a pilot 4-week open-label clinical trial.#123114
- Nicotinamide Riboside Clinical Trial for GWI#1046109
- Nicotinamide Riboside Supplementation and Exercise Training to Promote Healthy Longevity#1231896
- Rate of Pharmacotherapy for Tobacco Smoking Cessation in Patients With New Peripheral Artery Disease#1053001
- VASCULAR CONTRIBUTIONS TO COGNITIVE DECLINE: THE CONJUNCTIVAL MICROVASCULATURE, HOMOCYSTEINE, AND DIET AS EARLY BIOMARKERS#413186
Record · ID 1362845
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive